Influence of obesity on drug disposition

scientific article published on September 1987

Influence of obesity on drug disposition is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P698PubMed publication ID3315402

P2093author name stringMann HJ
Blouin RA
Kolpek JH
P433issue9
P921main subjectobesityQ12174
P304page(s)706-714
P577publication date1987-09-01
P1433published inClinical pharmacyQ27710474
P1476titleInfluence of obesity on drug disposition
P478volume6

Reverse relations

cites work (P2860)
Q37348793Anthropomorphic measurements and event-free survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology Group
Q72281596Antipyrine disposition in obesity: evidence for negligible effect of obesity on hepatic oxidative metabolism
Q34075909Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance
Q28545175Association of body composition with outcome of docetaxel chemotherapy in metastatic prostate cancer: a retrospective review
Q35622690Auditing Analgesic Use in Post-operative Setting in a Teaching Hospital
Q89517242Case Report of Increased Exposure to Antiretrovirals following Sleeve Gastrectomy
Q34959952Chemotherapy dose adjustment for obese patients undergoing hematopoietic stem cell transplantation: a survey on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Q38121735Chemotherapy dosing in overweight and obese patients with cancer
Q30497854Clinical pharmacology in the adolescent oncology patient
Q36753468Effect of abnormal levels of serum components on antibiotic activity
Q35219011Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma
Q38062477Pharmacologic prevention of venous thromboembolism in obese patients
Q37802505Pharmacotherapy in the Critically Ill Obese Patient
Q37660706Population Pharmacokinetics Modeling of Unbound Efavirenz, Atazanavir, and Ritonavir in HIV-Infected Subjects With Aging Biomarkers
Q48543700Quantitative peptidomics in mice: effect of cocaine treatment
Q36442549The Chinese Pueraria root extract (Pueraria lobata) ameliorates impaired glucose and lipid metabolism in obese mice
Q88215222The Influence of Obesity on the Pharmacokinetics of Dioxin in Mice: An Assessment Using Classical and PBPK Modeling
Q34137313The effect of bamboo extract on hepatic biotransforming enzymes – Findings from an obese–diabetic mouse model
Q33714092The role of adipose tissue and obesity in causing treatment resistance of acute lymphoblastic leukemia